Forge Biologics Holdings, LLC

GROVE CITY, OH · Founded 2020 · CIK 0001820029 · Biotech · Acquired

High-yield AAV (adeno-associated virus) manufacturing platform and cGMP facility for gene therapy production

forgebiologics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$160M
2 Form D · May 2021
65 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$40,000,000
Private capital raisedForm D · SEC$119,999,889
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2790Arbor Biotechnologies—$227M
2791Metsera—$215M
2792Affinivax, Inc.—$233M
2793Forge Biologics Holdings, LLC—$160M
2794Empress Therapeutics——
2795Octant Bio——
2796Enable Therapeutics LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Molly BonakdarpourDirector
  • Frederick CalloriDirector
  • Chris GarabedianDirector
  • Matthew HammondDirector
  • Molly McCartinDirector
  • Timothy MillerDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.